Anti-inflammatory and neuroprotective effects of triptolide on traumatic brain injury in rats

Respiratory Physiology and Neurobiology

Volumn 182, Issue 1, 2012, Pages 1-8

  Lee, Hung Fu ^a,b   Lee, Tzong Shyuan ^a   Kou, Yu Ru ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Cytokines; Inflammation; Traumatic brain injury; Triptolide

Indexed keywords

INTERLEUKIN 10; TRIPTOLIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BRAIN CONTUSION; BRAIN DAMAGE; BRAIN EDEMA; COGNITION; CONTROLLED STUDY; MALE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BRAIN EDEMA; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DITERPENES; EPOXY COMPOUNDS; INFLAMMATION MEDIATORS; MALE; NEURONS; NEUROPROTECTIVE AGENTS; PHENANTHRENES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION;

EID: 84862785508     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2012.01.016     Document Type: Article

References (47)

1. Ahmad M., Rose M.E., Vagni V., Griffith R.P., Dixon C.E., Kochanek P.M., Hickey R.W., Graham S.H. Genetic disruption of cyclooxygenase-2 does not improve histological or behavioral outcome after traumatic brain injury in mice. J. Neurosci. Res. 2008, 86:3605-3612.
2. Bareyre F., Wahl F., McIntosh T.K., Stutzmann J.M. Time course of cerebral edema after traumatic brain injury in rats: effects of riluzole and mannitol. J. Neurotrauma 1997, 14:839-849.
3. Bouet V., Boulouard M., Toutain J., Divoux D., Bernaudin M., Schumann-Bard P., Freret T. The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat. Protoc. 2009, 4:1560-1564.
4. Candelario-Jalil E., Taheri S., Yang Y., Sood R., Grossetete M., Estrada E.Y., Fiebich B.L., Rosenberg G.A. Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-α in the rat. J. Pharmacol. Exp. Ther. 2007, 323:488-498.
5. Chen G., Shi J.X., Hang C.H., Xie W., Liu J., Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model. A potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci. Lett. 2007, 425:177-182.
6. Chen S., Pickard J.D., Harris N.G. Time course of cellular pathology after controlled cortical impact injury. Exp. Neurol. 2003, 182:87-102.
7. Chio C.C., Lin J.W., Chang M.W., Wang C.C., Kuo J.R., Yang C.Z., Chang C.P. Therapeutic evaluation of etanercept in a model of traumatic brain injury. J. Neurochem. 2010, 115:921-929.
8. Csuka E., Morganti-Kossmann M.C., Lenzlinger P.M., Joller H., Trentz O., Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood-brain barrier function. J. Neuroimmunol. 1999, 101:211-221.
9. Donkin J.J., Vink R. Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments. Curr. Opin. Neurol. 2010, 23:293-299.
10. Fahrig T., Gerlach I., Horvath E. A synthetic derivative of the natural product rocaglaol is a potent inhibitor of cytokine-mediated signaling and shows neuroprotective activity in vitro and in animal models of Parkinson's disease and traumatic brain injury. Mol. Pharmacol. 2005, 67:1544-1555.
11. Faul J.L., Nishimura T., Berry G.J., Benson G.V., Pearl R.G., Kao P.N. Triptolide attenuates pulmonary arterial hypertension and neointimal formation in rats. Am. J. Respir. Crit. Care Med. 2000, 162:2252-2258.
12. Gong Y., Xue B., Jiao J., Jing L., Wang X. Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia. J. Neurochem. 2008, 107:779-788.
13. Hamm R.J. Neurobehavioral assessment of outcome following traumatic brain injury in rats: an evaluation of selected measures. J. Neurotrauma 2001, 18:1207-1216.
14. Hoyle G.W., Hoyle C.I., Chen J., Chang W., Williams R.W., Rando R.J. Identification of triptolide, a natural diterpenoid compound, as an inhibitor of lung inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 2010, 298:L830-L836.
15. Ikeda-Matsuo Y., Tanji H., Narumiya S., Sasaki Y. Inhibition of prostaglandin E2 EP3 receptors improves stroke injury via anti-inflammatory and anti-apoptotic mechanisms. J. Neuroimmunol. 2011, 238:34-43.
16. Jiao J., Xue B., Zhang L., Gong Y., Li K., Wang H., Jing L., Xie J., Wang X. Triptolide inhibits amyloid β1-42-induced TNF-α and IL-1β production in cultured rat microglia. J. Neuroimmunol. 2008, 205:32-36.
17. Kelso M.L., Pauly J.R. Therapeutic targets for neuroprotection and/or enhancement of functional recovery following traumatic brain injury. Prog. Mol. Biol. Transl. Sci. 2011, 98:85-131.
18. Kim Y.H., Lee S.H., Lee J.Y., Choi S.W., Park J.W., Kwon T.K. Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase. Eur. J. Pharmacol. 2004, 494:1-9.
19. Krakauer T., Chen X., Howard O.M., Young H.A. Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol. Immunotoxicol. 2005, 27:53-66.
20. Kunz T., Marklund N., Hillered L., Oliw E.H. Cyclooxygenase-2, prostaglandin synthases, and prostaglandin H2 metabolism in traumatic brain injury in the rat. J. Neurotrauma 2002, 19:1051-1064.
21. Lenzlinger P.M., Morganti-Kossmann M.C., Laurer H.L., McIntosh T.K. The duality of the inflammatory response to traumatic brain injury. Mol. Neurobiol. 2001, 24:169-181.
22. Li R., Takazawa K., Suzuki H., Hariya A., Yamamoto T., Matsushita S., Hirose H., Amano A. Synergistic effect of triptolide and tacrolimus on rat cardiac allotransplantation. Jpn. Heart J. 2004, 45:657-665.
23. Li W., Liu Y., He Y.Q., Zhang J.W., Gao Y., Ge G.B., Liu H.X., Huo H., Liu H.T., Wang L.M., Sun J., Wang Q., Yang L. Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes. Xenobiotica 2008, 38:1551-1565.
24. Lin N., Liu C., Xiao C., Jia H., Imada K., Wu H., Ito A. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Biochem. Pharmacol. 2007, 73:136-146.
25. Liu L., Jiang Z., Liu J., Huang X., Wang T., Liu J., Zhang Y., Zhou Z., Guo J., Yang L., Chen Y., Zhang L. Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats. Toxicology 2010, 271:57-63.
26. Liu Q. Triptolide and its expanding multiple pharmacological functions. Int. Immunopharmacol. 2011, 11:377-383.
27. Liu Q., Chen T., Chen G., Li N., Wang J., Ma P., Cao X. Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation. Biochem. Biophys. Res. Commun. 2006, 345:1122-1130.
28. Lu K.T., Wang Y.W., Yang J.T., Yang Y.L., Chen H.I. Effect of interleukin-1 on traumatic brain injury-induced damage to hippocampal neurons. J. Neurotrauma 2005, 22:885-895.
29. Lu Y., Liu Y., Fukuda K., Nakamura Y., Kumagai N., Nishida T. Inhibition by triptolide of chemokine, proinflammatory cytokine, and adhesion molecule expression induced by lipopolysaccharide in corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 2006, 47:3796-3800.
30. Matta R., Wang X., Ge H., Ray W., Nelin L.D., Liu Y. Triptolide induces anti-inflammatory cellular responses. Am. J. Transl. Res. 2009, 1:267-282.
31. Morganti-Kossmann M.C., Rancan M., Otto V.I., Stahel P.F., Kossmann T. Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 2001, 6:165-177.
32. Mori T., Wang X., Jung J.C., Sumii T., Singhal A.B., Fini M.E., Dixon C.E., Alessandrini A., Lo E.H. Mitogen-activated protein kinase inhibition in traumatic brain injury: in vitro and in vivo effects. J. Cereb. Blood Flow Metab. 2002, 22:444-452.
33. Qiu D., Kao P.N. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook F. Drugs R. D. 2003, 4:1-18.
34. Raghupathi R., Graham D.I., McIntosh T.K. Apoptosis after traumatic brain injury. J. Neurotrauma 2000, 17:927-938.
35. Sharma H.S., Westman J., Cervós-Navarro J., Nyberg F. Role of neurochemicals in brain edema and cell changes following hyperthermic brain injury in the rat. Acta Neurochir. Suppl. 1997, 70:269-274.
36. Shohami E., Novikov M., Bass R., Yamin A., Gallily R. Closed head injury triggers early production of TNF-α and IL-6 by brain tissue. J. Cereb. Blood Flow Metab. 1994, 14:615-619.
37. Shohami E., Gallily R., Mechoulam R., Bass R., Ben-Hur T. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant. J. Neuroimmunol. 1997, 72:169-177.
38. Stahel P.F., Shohami E., Younis F.M., Kariya K., Otto V.I., Lenzlinger P.M., Grosjean M.B., Eugster H.P., Trentz O., Kossmann T., Morganti-Kossmann M.C. Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J. Cereb. Blood Flow Metab. 2000, 20:369-380.
39. Stanley J.L., Lincoln R.J., Brown T.A., McDonald L.M., Dawson G.R., Reynolds D.S. The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines. J. Psychopharmacol. 2005, 19:221-227.
40. Strauss K.I. Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain. Brain Behav. Immun. 2008, 22:285-298.
41. Su Z., Yuan Y., Cao L., Zhu Y., Gao L., Qiu Y., He C. Triptolide promotes spinal cord repair by inhibiting astrogliosis and inflammation. Glia 2010, 58:901-915.
42. Tao X., Schulze-Koops H., Ma L., Cai J., Mao Y., Lipsky P.E. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Arthritis Rheum. 1998, 41:130-138.
43. Wu S.X., Guo N.R. Clinical observation on effect of triptolide tablet in treating patients with psoriasis vulgaris. Chin. J. Integr. Med. 2005, 11:147-148.
44. Zhang X., Chen Y., Jenkins L.W., Kochanek P.M., Clark R.S. Bench-to-bedside review: apoptosis/programmed cell death triggered by traumatic brain injury. Crit. Care 2005, 9:66-75.
45. Zhao G., Vaszar L.T., Qiu D., Shi L., Kao P.N. Anti-inflammatory effects of triptolide in human bronchial epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279:L958-L966.
46. Zhou H.F., Niu D.B., Xue B., Li F.Q., Liu X.Y., He Q.H., Wang X.H., Wang X.M. Triptolide inhibits TNF-α, IL-1β and NO production in primary microglial cultures. Neuroreport 2003, 14:1091-1095.
47. Ziebell J.M., Morganti-Kossmann M.C. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010, 7:22-30.